Selected Grants
Blood and Marrow Transplant Clinical Trials Network
Clinical TrialConsultant · Awarded by National Institutes of Health · 2001 - 2031Randomized Controlled Trial of a Hybrid-Delivered Cognitive Behavioral Symptom Management and Activity Coaching Intervention for Stem Cell Transplant Patients
ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2029Remotely Monitored, Mobile health-supported High Intensity Interval Training after COVID-19 Critical Illness (REMM HIIT-Covid19)
ResearchCo Investigator · Awarded by National Institutes of Health · 2021 - 2027Hematology & Transfusion Medicine (T32)
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 1975 - 2026Home-based Autologous Hematopoietic Stem Cell Transplantation to Improve Outcomes and Decrease Costs
ResearchPrincipal Investigator · Awarded by National Institute on Aging · 2020 - 2026Behavior and Physiology in Aging
Inst. Training Prgm or CMEMentor · Awarded by National Institute on Aging · 2015 - 2025A Randomized Phase 2 Trial to Evaluate Prebiotic Intervention in Allogeneic Hematopoietic Stem Cell Transplantation
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2020 - 2025Viral Oncology Training Grant
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1980 - 2025A Phase 3 randomized, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of letermovir (LET) prophylaxis when extended from 100days to 200 days post-transplant in cytomegalovirus (CMV) seropositive recipients (R+)
Clinical TrialPrincipal Investigator · Awarded by Merck Sharp & Dohme · 2019 - 2024REmotely Monitored, Mobile-Health High Intensity Interval Training after Critical Care (REMM-HIIT)
Clinical TrialCo Investigator · Awarded by Society of Critical Care Medicine · 2021 - 2024"A Randomized Study of Virtual Survivorship Support for Allogeneic Hematopoietic Stem Cell Transplant Survivors (Be The Match Survivorship Study)" (the "Study").
Clinical TrialPrincipal Investigator · Awarded by National Marrow Donor Program · 2021 - 2024Hematopoietic Stem Cell Transplantation Combined with CSF1 Inhibition to Attenuate the Pathogenesis of Alzheimer's Disease
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2023Home Transplant to Preserve the Microbiota and Decrease GVHD
ResearchPrincipal Investigator · Awarded by American Society of Hematology · 2019 - 2022Personalized Prebiotics to Optimize Microbiota Metabolism and Improve Transplant Outcomes
ResearchPrincipal Investigator · Awarded by Damon Runyon Cancer Research Foundation · 2018 - 2022T32 UNC - Duke Immunotherapy Training Program
Inst. Training Prgm or CMEPreceptor · Awarded by University of North Carolina - Chapel Hill · 2021 - 2022Evaluating Effects of Age-related Microbiota Modulations in Hematopoietic Stem Cell Transplant Patients
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2019 - 2022Patient-centered home-based hematopoietic stem cell transplantation
Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2016 - 2022Development and Pilot Testing of a Hybrid In Person and mHealth Coping Skills Training Intervention for Symptom Management and Daily Steps in Stem Cell Transplant Patients
ResearchCo Investigator · Awarded by National Institutes of Health · 2019 - 2021Phase 3b/4 Safety Trial of Nivolumab Combined with Ipilmumab in Subjects with Previously Untreated, Advanced or Metastatic RCC
Clinical TrialPrincipal Investigator · Awarded by Merck Sharp & Dohme · 2018 - 2021Prevention of Gastrointestinal Toxicity from total body irradation or high dose Chemo with SOM230
ResearchPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2013 - 2021Personalized prebiotics to optimize microbiota metabolism and improve transplant outcomes(F)
ResearchCo-Mentor · Awarded by American Society of Hematology · 2020 - 2021Keratinocyte targeted strategies for treatment of cutaneous GVHD
ResearchCo Investigator · Awarded by National Institutes of Health · 2018 - 2021Microbiota-focused strategies to mitigate GVHD
ResearchPrincipal Investigator · Awarded by MD Anderson Cancer Center · 2015 - 2020AZD9668 and Neutrophil Elastase Inhibition to Prevent Graft-versus-Host Disease
ResearchCo Investigator · Awarded by National Institutes of Health · 2018 - 2019Effects of In-Home Hematopoietic Stem Cell Transplantation on the Gut Microbiota
FellowshipPrincipal Investigator · Awarded by American Society of Hematology · 2018 - 2019Duke CTSA (KL2)
ResearchScholar · Awarded by National Institutes of Health · 2013 - 2018External Relationships
- Acrotech
- Clasado
- DSM/iHealth
- Targazyme
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.